A Telephone Feedback System for Prevention of Chronic Pain Relapse

Chronic Pain and Relapse Prevention Clinical Trial

Official title:

Therapeutic Interactive Voice Response (IVR) for Relapse Prevention in Chronic Pain

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00266773
• Other study ID #: R01AR052131
• Secondary ID: R01AR0521315R01A
• Status: Completed
• Phase: N/A
• First received: December 16, 2005
• Last updated: February 15, 2013
• Start date: November 2005
• Est. completion date: January 2012

Study information

• Verified date: February 2013
• Source: University of Vermont
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether a telephone-based self-monitoring and skills review program with personalized therapist feedback following group CST for chronic pain can reduce and prevent relapse of the pain, physical disability, and psychological distress experienced by patients with chronic pain of the muscles and bone.

Description:

IVR (Interactive Voice Response) is a computer-based, automated telephone system that enables callers to respond to a recorded voice via the telephone keypad. Using this technology, therapeutic IVR (TIVR) was developed as a tool for providing maintenance treatment following group cognitive-behavioral coping skills training (CST), a widely-used behavioral treatment for chronic pain. TIVR has four components:

• an automated daily questionnaire for self-monitoring

• a review of coping skills

• guided behavioral rehearsals of CST coping skills

• personalized monthly feedback messages recorded onto TIVR by the therapist

All four components can be accessed remotely by patients via any touch-tone phone. In a small pilot study, people with severe, chronic musculoskeletal pain received 11 weeks of either CST alone or CST with TIVR access and therapist feedback. Those who used TIVR had better pain outcomes than those who did not. This study will compare the effectiveness of TIVR with or without therapist feedback to a control group not using TIVR at all.

To be eligible for this study, participants must have just completed an 11-week course of CST through the University of Vermont College of Medicine's MindBody Medicine Clinic. At study entry, participants will be randomly assigned to one of three groups. Group 1 is a control group that will not receive any intervention through this study. Group 2 participants will receive full access to TIVR and will get a minimal monthly message from their therapist, who will not use the participant's daily questionnaire data. Group 3 participants will receive full access to TIVR and will get personalized monthly messages from their therapist based on the participant's daily questionnaire data. Messages for participants will include any trends the therapist has noted in a participant's stress, sleep, mood, pain levels, coping, and activity, as reported through TIVR. All study participants may continue to receive treatment from their regular physician or take part in other pain management techniques during this study, but such treatment will not be provided through this study.

Upon completing the 11 weeks of CST, all participants will be asked to complete a packet of questionnaires about their chronic pain. At the start of this study, participants in Groups 2 and 3 will have a 30-minute training session on how to use and access TIVR. At Months 4, 8, and 12, participants from all three groups will have follow-up interviews and will complete additional questionnaires.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 158
• Est. completion date: January 2012
• Est. primary completion date: January 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Completed 11 weeks of CST through the University of Vermont College of Medicine - Health Behavior Research Center prior to study entry

• At least 6 months of musculoskeletal pain caused by back, neck, or shoulder pain; osteoarthritis; or fibromyalgia

• Meet study threshold for pain severity with a Typical Pain score of 4 or more on a 10-point scale adapted from the McGill Pain Questionnaire (80)

• Receiving ongoing standard pain management from a physician (typically involving oral analgesic medication and physical therapy, with or without anesthetic or steroid injections)

Exclusion Criteria:

• Unable to perform usual self care

• Cancer that causes or influences patient's chronic pain

• Cancer requiring radiation or chemotherapy or metastatic cancer of any type

• Reflex sympathetic dystrophy (RSD)

• Neuropathic pain

• Awaiting a pain-related surgical procedure

• Involved in pain-related litigation or awaiting disability determination

• Behavioral problems or psychotic disorders that may interfere with the study

• Inability to use telephone-based TIVR due to cognitive or hearing impairment

• At risk for suicide

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Chronic Pain
• Chronic Pain and Relapse Prevention

Intervention

Behavioral:
• Chronic pain therapeutic interactive voice response (TIVR) system
Therapeutic Interactive Voice Response as a daily self monitoring and relapse prevention tool with didactic reviews and practices of recorded skills and monthly feedback based on daily calls

Locations

Country	Name	City	State
United States	University of Vermont College of Medicine - MindBody Medicine Clinic	Burlington	Vermont

Sponsors (3)

Lead Sponsor	Collaborator
University of Vermont	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), University of Vermont Medical Center

Country where clinical trial is conducted

United States, 

References & Publications (2)

Keefe FJ, Rumble ME, Scipio CD, Giordano LA, Perri LM. Psychological aspects of persistent pain: current state of the science. J Pain. 2004 May;5(4):195-211. Review. — View Citation

Naylor MR, Helzer JE, Naud S, Keefe FJ. Automated telephone as an adjunct for the treatment of chronic pain: a pilot study. J Pain. 2002 Dec;3(6):429-38. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Total pain experience and physical and social disability (as measured by the TOPS)		12 months	No
Primary	Pain level (as measured by the McGill Pain Questionnaire)		12 months	No
Primary	Catastrophizing and perceptions of control (as measured by the Coping Strategies Questionnaire)		12 months	No
Secondary	Utilization of telephone system components during the study		daily for 6 months	No
Secondary	Daily ratings of mood, pain, and coping use (measured by the TIVR Daily Questionnaire)		daily for 6 months	No
Secondary	General measure of depressive symptoms (measured by the Beck Depression Inventory)		12 months	Yes

External Links

•   Click here for the University of Vermont College of Medicine - MindBody Medicine Clinic Web site